A randomized controlled trial comparing repeat doses of 400 mcg sublingual to buccal misoprostol after mifepristone for termination of pregnancy 13–21 weeks
Autor: | Dabash, R., Chong, E., Bracken, H., Tsereteli, T., Abrahamyan, R., Hajri, S., Karki, C., Sfar, E., Kurbanbekova, D., Bajracharya, J., Sadikova, D., Shochet, T., Platais, I., Tan, Y.L., Murtagh, C., Winikoff, B. |
---|---|
Zdroj: | In Contraception May 2017 95(5):515-515 |
Databáze: | ScienceDirect |
Externí odkaz: |